- Home
- APLM vs SDOT Comparison
APLM vs SDOT Comparison
Compare APLM & SDOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- SDOT
- Stock Information
- Founded
- APLM 2016
- SDOT 2014
- Country
- APLM United States
- SDOT United States
- Employees
- APLM N/A
- SDOT N/A
- Industry
- APLM Blank Checks
- SDOT Restaurants
- Sector
- APLM Finance
- SDOT Consumer Discretionary
- Exchange
- APLM Nasdaq
- SDOT Nasdaq
- Market Cap
- APLM 6.9M
- SDOT 8.0M
- IPO Year
- APLM N/A
- SDOT 2020
- Fundamental
- Price
- APLM $6.14
- SDOT $1.39
- Analyst Decision
- APLM
- SDOT
- Analyst Count
- APLM 0
- SDOT 0
- Target Price
- APLM N/A
- SDOT N/A
- AVG Volume (30 Days)
- APLM 7.8K
- SDOT 591.6K
- Earning Date
- APLM 08-13-2025
- SDOT 08-12-2025
- Dividend Yield
- APLM N/A
- SDOT N/A
- EPS Growth
- APLM N/A
- SDOT N/A
- EPS
- APLM N/A
- SDOT 1.07
- Revenue
- APLM $198,000.00
- SDOT $726,598,000.00
- Revenue This Year
- APLM $415.15
- SDOT $12.76
- Revenue Next Year
- APLM N/A
- SDOT $5.54
- P/E Ratio
- APLM N/A
- SDOT $1.30
- Revenue Growth
- APLM N/A
- SDOT 18.91
- 52 Week Low
- APLM $4.47
- SDOT $1.12
- 52 Week High
- APLM $35.98
- SDOT $7.00
- Technical
- Relative Strength Index (RSI)
- APLM 47.85
- SDOT 47.94
- Support Level
- APLM $6.21
- SDOT $1.33
- Resistance Level
- APLM $6.80
- SDOT $1.52
- Average True Range (ATR)
- APLM 0.52
- SDOT 0.20
- MACD
- APLM 0.00
- SDOT -0.01
- Stochastic Oscillator
- APLM 51.61
- SDOT 12.99
About APLM Apollomics Inc.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About SDOT Sadot Group Inc.
Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.